Pro-Leu pairs a turn-inducing proline with hydrophobic leucine, creating a dipeptide ideal for studying β-turn and helix-capping behavior. Backbone constraints imposed by proline strongly influence conformational preferences. Researchers assess its role in local structure formation within larger peptides. Applications include folding simulations, motif design, and enzyme-recognition studies.
CAT No: R2573
CAS No:52899-07-7
Synonyms/Alias:H-Pro-Leu-OH;52899-07-7;Pro-leu;L-prolyl-L-leucine;(S)-4-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoic acid;L-Pro-L-Leu;CHEBI:74791;CHEMBL293494;(2S)-4-methyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]pentanoic acid;L-Leucine, L-prolyl-;DTXSID80393341;Prolyl-leucine;(2S)-4-methyl-2-(((2S)-pyrrolidin-1-ium-2-carbonyl)amino)pentanoate;(2S)-4-methyl-2-(((2S)-pyrrolidine-2-carbonyl)amino)pentanoic acid;(2S)-4-methyl-2-[[(2S)-pyrrolidin-1-ium-2-carbonyl]amino]pentanoate;((Benzyloxy)carbonyl)-L-prolyl-D-leucine;MFCD00037871;SCHEMBL6373762;DTXCID70344201;BDBM50188501;STL527240;AKOS010421057;CS-W010402;HY-W009686;DA-64268;FP108158;G82709;Q27144902;4-Methyl-2-[(pyrrolidine-2-carbonyl)-amino]-pentanoic acid;(S)-4-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoicacid;(S)-4-Methyl-2-[((S)-pyrrolidine-2-carbonyl)-amino]-pentanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.